tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
US Market
MLYS
Mineralys Therapeutics, Inc.
Overview
Analyst Forecasts
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Mineralys Therapeutics, Inc. (MLYS) Stock News & Sentiment

Compare
275 Followers
Mineralys Therapeutics Highlights Positive Earnings Call
Premium
Company Announcements
Mineralys Therapeutics Highlights Positive Earnings Call
9d ago
MLYS
Promising Outlook for Mineralys Therapeutics: Buy Rating Affirmed on Lorundrostat’s Potential
Premium
Ratings
Promising Outlook for Mineralys Therapeutics: Buy Rating Affirmed on Lorundrostat’s Potential
9d ago
MLYS
Mineralys Therapeutics Reports 2024 Earnings and Trial Progress
Premium
Company Announcements
Mineralys Therapeutics Reports 2024 Earnings and Trial Progress
10d ago
MLYS
Promising Growth Ahead: Mineralys Therapeutics Positioned for Success with Robust Financials and Key Hypertension Study Results
Premium
Ratings
Promising Growth Ahead: Mineralys Therapeutics Positioned for Success with Robust Financials and Key Hypertension Study Results
10d ago
MLYS
Is MLYS a Buy, Before Earnings?
Premium
Pre-Earnings
Is MLYS a Buy, Before Earnings?
12d ago
MLYS
Mineralys Therapeutics Completes Enrollment for Key Trial
Premium
Company Announcements
Mineralys Therapeutics Completes Enrollment for Key Trial
18d ago
8K
MLYS
Mineralys Therapeutics Advances Lorundrostat to Phase 2 Trials
Premium
Company Announcements
Mineralys Therapeutics Advances Lorundrostat to Phase 2 Trials
2M ago
8K
MLYS
More MLYS News >

MLYS News on the Web

Mineralys Therapeutics Highlights Positive Earnings Call
TipRanks News
Neutral
Q4 2024 Mineralys Therapeutics Inc Earnings Call
Yahoo Finance
Neutral
Mineralys Therapeutics Inc Q4 2024 Earnings Call Highlights: Navigating Increased ...
Yahoo Finance
Neutral
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Yahoo Finance
Neutral
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025
Yahoo Finance
Neutral
Mineralys Therapeutics Completes Enrollment in Explore-CKD Phase 2 Trial of Lorundrostat for the Treatment of Hypertension in Subjects with Stage 2 to 3b CKD and Albuminuria
Yahoo Finance
Neutral
Strategic Advancements and FDA Clearance Propel Mineralys Therapeutics to a Buy Rating
TipRanks News
Bullish
Mineralys Therapeutics, Inc. (MLYS) Receives a Buy from Wells Fargo
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
MLYS
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MLYS’s Media Buzz Sentiment?
Currently, no data Available
What is MLYS’s weekly average amount of articles?
Currently, no data Available
What is MLYS’s News Sentiment?
59% of articles about MLYS were positive this week, compared to its sector average of 57%.
    Healthcare Stocks that are Trending in the News
    SHGSingular Health Group Ltd
    RCUSArcus Biosciences
    HCMHUTCHMED
    PENPenumbra
    AMNAMN Healthcare Services
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing